(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate
![(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate Structure](CAS/GIF/791616-63-2.gif)
- CAS No.
- 791616-63-2
- Chemical Name:
- (R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate
- Synonyms
- (R)-TRIP;1-d:1μ;6-bis[2;SF110001;(11bR)-4-Hydroxy-2;6-triisopropylphenyl)-1;(R)-TRIP or (R)-TRIP PA;2-dioxaphosphepin 4-oxide;1μ-bi-2-naphthol cyclic monophosphate;6-tris(1-methylethyl)phenyl]dinaphtho[2
- CBNumber:
- CB52093104
- Molecular Formula:
- C50H57O4P
- Molecular Weight:
- 752.98
- MOL File:
- 791616-63-2.mol
- Modify Date:
- 2025/1/27 9:38:02
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate Properties
Boiling point | 814.2±75.0 °C(Predicted) |
---|---|
Density | 1.17±0.1 g/cm3(Predicted) |
storage temp. | Inert atmosphere,Room Temperature |
pka | 1.12±0.20(Predicted) |
form | Powder |
color | white to light-yellow |
InChIKey | AGQAQYPGJDBIQR-UHFFFAOYSA-N |
SMILES | O=P1(OC2C(C3C(=CC(C(C)C)=CC=3C(C)C)C(C)C)=CC3=CC=CC=C3C=2C2C3=CC=CC=C3C=C(C3C(=CC(C(C)C)=CC=3C(C)C)C(C)C)C=2O1)O |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Danger |
Hazard statements | H315-H319-H335 |
Precautionary statements | P261-P280-P305+P351+P338-P304+P340-P405-P501A |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
WGK Germany | 3 |
TSCA | No |
HS Code | 29199000 |
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate price More Price(2)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | 689890 | (R)-3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate ≥97.0% (qNMR) | 791616-63-2 | 100MG | ₹27928.5 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | 689890 | (R)-3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate ≥97.0% (qNMR) | 791616-63-2 | 500MG | ₹89284.6 | 2022-06-14 | Buy |
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate Chemical Properties,Uses,Production
Uses
Versatile organocatalyst. Uses include asymmetric reductive amination, enantioselective Diels-Alder reactions and asymmetric counteranion-directed catalysis (ACDC). Can be used in cooperation with chiral iridium complexes to catalyze greener asymmetric reductive amination using hydrogen gas.
Metal-Br?nsted Acid Cooperative Catalysis for Asymmetric Reductive Amination
General Description
This product has been enhanced for catalytic efficiency.
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 79)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Golden Pharma Co., Limited | +undefined18958062155 | China | 5899 | 58 | Inquiry |
XINXIANG RUNYU MATERIAL CO., LTD. | +86-13592593621; +8613592593621 | China | 408 | 58 | Inquiry |
Shanghai Daken Advanced Materials Co.,Ltd | +86-371-+86-371-66670886 | China | 19809 | 58 | Inquiry |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | China | 33024 | 60 | Inquiry |
Zhengzhou Alfa Chemical Co.,Ltd | +8618530059196 | China | 12162 | 58 | Inquiry |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | China | 30231 | 58 | Inquiry |
LEAP CHEM CO., LTD. | +86-852-30606658 | China | 24727 | 58 | Inquiry |
Protheragen-ING | +16313385890 | United States | 3868 | 58 | Inquiry |
Shanghai Acmec Biochemical Technology Co., Ltd. | +86-18621343501; +undefined18621343501 | China | 33338 | 58 | Inquiry |
R&D Scientific Inc. | +1-2266000236 | Canada | 1759 | 58 | Inquiry |
791616-63-2((R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate)Related Search:
(11bS)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
S-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-4-Hydroxy-2,6-bis(4-methoxyphenyl)-4-oxidedinaphtho[
2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide
R-4-oxide-4-hydroxy-2,6-bis(4-Methoxyphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
Ir(I)/(S)-t-Bu-PHOX
S-3,3'-Bis(phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
R-3,3'-Bis(phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
R-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide
chevron_left
1of3
chevron_right
(R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-binaphthyl-2,2μ-diyl hydrogenphosphate
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate
(R)-3,3'-Bis(2,4,6-triisopropylphenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate >=97.5% (HPLC)
(S)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-binaphthyl-2,2μ-diyl hydrogenphosphate
(2r)-4-hydroxy-2,6-bis(2,4,6-triisopropylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
(R)-3,3'-Bis(2,4,6-triisopropylphenyl)-1,1'-binaphthyl-2,2'-
diyl Hydrogen Phosphate,99%e.e.
(11BR)-4-HYDROXY-2,6-BIS[2,4,6-TRIS(1-METHYLETHYL)PHENYL]-4-OXIDE-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN,98%,(99%EE)
(R)-3,3'-Bis(2,4,6-trisopropylphenyl)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate
(11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide
(11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]
dioxaphosphepin(R-TRIP)
(11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
SF110001
Dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin, 4-?hydroxy-?2,?6-?bis[2,?4,?6-?tris(1-?methylethyl)?phenyl]?-?, 4-?oxide, (11bR)?-
(11bR)-4-Hydroxy-2,6-bis(2,4,6-triisopropylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d
(11bR)-4-Hydroxy-2
1-d:1μ
1μ-bi-2-naphthol cyclic monophosphate
2-dioxaphosphepin 4-oxide
6-bis[2
6-triisopropylphenyl)-1
6-tris(1-methylethyl)phenyl]dinaphtho[2
(R)-TRIP or (R)-TRIP PA
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin
(R)-TRIP
(11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin
(R)-4-hydroxy-2,6-bis(2,4,6-triisopropylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
4-hydroxy-2,6-bis(2,4,6-triisopropylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
(R)-3,3'-Bis(2,4,6-triisopropylphenyl)-1,1'-binaphthyl-2,2'-diyl Hydrogenphosphate
13-hydroxy-10,16-bis[2,4,6-tri(propan-2-yl)phenyl]-12,14-dioxa-13lambda5-phosphapentacyclo[13.8.0.02,11.03,8.018,23]tricosa-1(15),2(11),3,5,7,9,16,18,20,22-decaene 13-oxide
(R)-3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate
(R)-4-hydroxy-2,6-bis(2,4,6-triisopropylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphat
791616-63-2
C50H57O4P